6 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
Recommendations for Cryptococcal ... week) >1 year #Cryptococcal ... IDSA #Treatment #management ... #meningitis #cryptococcus ... #HIVAIDS
Immunosuppression in Transplantation
Induction (I):
 - Basiliximab (Simulect)
 - Alemtuzumab (Campath)
 - Rituximab
 - Anti-Thymocyte Globulin (ATG)
Induction
Transplantation Induction ... Globulin (ATG) Induction ... #Medications #Pharmacology ... #Maintenance #Management ... #Nephrology #Renal
Hematuria in Post-Renal Transplant Patient
Prevalence up to 12% in the postrenal transplant patient
 • Bacterial: Escherichia
Fungal: Candida, Cryptococcus ... Other: Chronic rejection ... #blood #urine #management ... #treatment #nephrology
Impact and Challenges With Vitamin D to Treat Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease
calcitriol - Noted reduction ... SHPT - Noted reduction ... edgarvlermamd - Nephrology ... Hyperparathyroidism #CKD #Nephrology ... #Management #Pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
of successful induction ... Cryptococcosis #Cryptococcus ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Disseminated Disease Induction ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology